Inventor · disambiguated record
Zongbin Li
Also filed as: LI ZONGBIN
4 granted patents·4 pending applications·28 citations·filing 2016–2023
69Inventor score
Files withASCENTAGE PHARMA SUZHOU CO LTD3CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2JIANGSU KANION PARMACEUTICAL CO LTD1MEDSHINE DISCOVERY INC1QILU PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
8 records- 0192US10253030B2Crystal form, preparation method and intermediate of dihydropyrido ring compoundQILU PHARMACEUTICAL CO LTD·Filed 2016·Granted Apr 9, 2019·25 cites·26 claims
- 0279US10626107B2Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Apr 21, 2020·2 cites·16 claims
- 0367US10227339B2Salt form and crystal form of 1,2,5-thiadiazolidin-1,1-dioxide, preparation method thereof and intermediateJIANGSU KANION PARMACEUTICAL CO LTD·Filed 2016·Granted Mar 12, 2019·1 cites·8 claims
- 0457US2025109134A1Crystalline form or amorphous form of macrocyclic compound or salt or solvate thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 0551US10479789B2Pyrido[1,2-A]pyrimidone analog, crystal form thereof, intermediate thereof and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Nov 19, 2019·0 cites·17 claims
- 0649US2023257384A1The crystalline forms or amorphous forms of bisdiazabicyclic compounds or salts thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0746US2023064976A1Amorphous form or crystalline form of 2-indolinolinololylspironone compounds or their salts, solvent complexesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 0837US2019276475A1Crystal and salt of nitroimidazole, and manufacturing method thereofMEDSHINE DISCOVERY INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zongbin Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →